Business Description
Ever Supreme Bio Technology Co Ltd
ISIN : TW0006712003
Total Employee Number:
87Description
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.55 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.39 | |||||
Interest Coverage | 577.9 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 14.56 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.9 | |||||
3-Year EBITDA Growth Rate | 23.7 | |||||
3-Year EPS without NRI Growth Rate | 30.4 | |||||
3-Year FCF Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | -4.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.31 | |||||
9-Day RSI | 52.6 | |||||
14-Day RSI | 53.27 | |||||
3-1 Month Momentum % | 6.55 | |||||
6-1 Month Momentum % | 5.72 | |||||
12-1 Month Momentum % | -2.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 1.57 | |||||
Days Inventory | 104.66 | |||||
Days Sales Outstanding | 46.82 | |||||
Days Payable | 31.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.12 | |||||
Dividend Payout Ratio | 0.67 | |||||
3-Year Dividend Growth Rate | 7.4 | |||||
Forward Dividend Yield % | 2.12 | |||||
5-Year Yield-on-Cost % | 2.12 | |||||
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 2.55 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.66 | |||||
Operating Margin % | 44.15 | |||||
Net Margin % | 43.78 | |||||
EBITDA Margin % | 55.85 | |||||
FCF Margin % | 58.32 | |||||
OCF Margin % | 58.41 | |||||
ROE % | 24.13 | |||||
ROA % | 18.67 | |||||
ROIC % | 19.6 | |||||
3-Year ROIIC % | 15.67 | |||||
ROC (Joel Greenblatt) % | 784.99 | |||||
ROCE % | 28.82 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 31.69 | |||||
Forward PE Ratio | 26.66 | |||||
PE Ratio without NRI | 31.69 | |||||
Shiller PE Ratio | 96.32 | |||||
Price-to-Owner-Earnings | 27.1 | |||||
PS Ratio | 13.83 | |||||
PB Ratio | 5.6 | |||||
Price-to-Tangible-Book | 9.19 | |||||
Price-to-Free-Cash-Flow | 24.08 | |||||
Price-to-Operating-Cash-Flow | 24.04 | |||||
EV-to-EBIT | 25.64 | |||||
EV-to-EBITDA | 24.67 | |||||
EV-to-Revenue | 13.79 | |||||
EV-to-FCF | 24.35 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Projected-FCF | 2.18 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.27 | |||||
Price-to-Graham-Number | 3.6 | |||||
| Price-to-Net-Current-Asset-Value | 28.87 | |||||
| Price-to-Net-Cash | 47.28 | |||||
Earnings Yield (Greenblatt) % | 3.91 | |||||
FCF Yield % | 4.02 | |||||
Forward Rate of Return (Yacktman) % | 22.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ever Supreme Bio Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,081.139 | ||
| EPS (TTM) (NT$) | 4.938 | ||
| Beta | 0.4482 | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 36.98 | ||
| 14-Day RSI | 53.27 | ||
| 14-Day ATR (NT$) | 4.305691 | ||
| 20-Day SMA (NT$) | 154.05 | ||
| 12-1 Month Momentum % | -2.64 | ||
| 52-Week Range (NT$) | 120.952381 - 184 | ||
| Shares Outstanding (Mil) | 100.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ever Supreme Bio Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ever Supreme Bio Technology Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.05:1 Stock Split | 2026-05-14 | 132.38 (-0.36%) | ||
| TWD 3.333333 Cash Dividend | 2026-04-16 | 136.67 (+0.35%) | ||
| 1.1:1 Stock Split | 2025-06-03 | 151.08 (+2.05%) | ||
| TWD 4.433759 Cash Dividend | 2025-04-30 | 149.78 (+1.76%) | ||
| 1.1:1 Stock Split | 2024-05-29 | 158.99 (+0.25%) | ||
| 1.09965:1 Stock Split | 2023-05-29 | 146.73 (-2.38%) | ||
| 1.1:1 Stock Split | 2022-05-19 | 130.14 (+1.52%) |
Show
Entries
Ever Supreme Bio Technology Co Ltd Frequently Asked Questions
What is Ever Supreme Bio Technology Co Ltd(ROCO:6712)'s stock price today?
The current price of ROCO:6712 is NT$156.50. The 52 week high of ROCO:6712 is NT$184.00 and 52 week low is NT$120.95.
When is next earnings date of Ever Supreme Bio Technology Co Ltd(ROCO:6712)?
The next earnings date of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is .
Does Ever Supreme Bio Technology Co Ltd(ROCO:6712) pay dividends? If so, how much?
The Dividend Yield %  of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is 2.12% (As of Today), Highest Dividend Payout Ratio of Ever Supreme Bio Technology Co Ltd(ROCO:6712) was 1.71. The lowest was 0.28. And the median was 1.14. The  Forward Dividend Yield % of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is 2.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ever Supreme Bio Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers